MRFF 2021 Clinical Trials Activity Grant Opportunity

Overview

Applications must address the objectives and desired outcomes described in section 1.3 of the grant guidelines. Applications to this grant opportunity must propose research that addresses one of the six Streams of research.  An application may be submitted to one of the six Streams only. The objective of this grant opportunity is addressed in the following six Streams: Rare Cancers, Rare Diseases and Unmet Need Stream 1 – Conduct a clinical trial of new drug and/or non-drug treatments and therapies for rare cancers, rare diseases and/or unmet needs. Stream 2 – Conduct a clinical trial assessing the safety, effectiveness and acceptability, of neurostimulation for improving outcomes in patients with spinal cord injury. Stream 3 – Conduct a clinical trial assessing the safety, effectiveness and acceptability, of pharmacological and/or non- pharmacological interventions for improving outcomes in individuals with chronic pain. Effective Health Interventions Stream 4 - Conduct a clinical trial of new drug and/or non-drug treatments and therapies in individuals who have been identified through molecular testing. Stream 5 – Conduct an implementation science trial to determine best ways to implement preventative health interventions, screening or diagnostic test, therapeutic agent, technology or model of care that is not in routine use in Australia. Stream 6 – Conduct a clinical trial assessing the comparative effectiveness and acceptability of health interventions in improving outcomes in individuals with complex chronic conditions, including comorbidities. This grant opportunity is being administered by NHMRC on behalf of the Australian Government Department of Health.  Further information on the Medical Research Future Fund is available from the Department of Health website.